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CASE
A60-year-old female was admitted to a hospital in Missouri with back pain andpathological fractures of multiple thoracic vertebrae. Four months prior to presen-
tation, the patient began experiencing low back pain without inciting trauma. Over the
next 2 months, the pain continued to worsen and she experienced a 20-lb weight loss
and drenching night sweats, prompting her to seek care. During the initial encounter,
the patient denied experiencing fevers. She was not immunocompromised and had no
risk factors for tuberculosis and no history of recent travel, hospitalization, or invasive
procedures. Magnetic resonance imaging (MRI) revealed abnormal enhancement and
edema involving the T6, T7, and T8 vertebral bodies with associated prevertebral and
postvertebral soft tissue enhancement and edema. A ﬂuoroscopy-guided T7 vertebral
body biopsy revealed acute and chronic osteomyelitis with no evidence of malignancy,
prompting an infectious disease consult.
Two sets of blood cultures (VersaTREK REDOX 1 and REDOX 2 media per set) were
obtained, and they signaled positive on the blood culture instrument (VersaTREK;
Thermo Fisher Scientiﬁc). The aerobic bottles from both sets yielded Gram-positive
cocci in clusters that were identiﬁed as Staphylococcus species by the VERIGENE
Gram-Positive Blood Culture Test (BC-GP) (Nanosphere/Luminex). Anaerobic medium
bottles remained negative. Subculture to sheep blood agar revealed beta-hemolytic
colonies that were subsequently identiﬁed as Staphylococcus schleiferi by matrix-
assisted laser desorption ionization–time of ﬂight (MALDI-TOF) mass spectrometry (MS)
with an acceptable species-level score of 2.151 (Bruker Biotyper, Reference Database
5.0; Bruker Daltonics, Billerica, MA).
A specimen from the T7 vertebral bone biopsy was sent for culture. Gram staining
of the specimen revealed rare polymorphonuclear leukocytes, and no organisms were
seen. Aerobic media (sheep blood agar, chocolate agar, and MacConkey agar) were
held for 3 days, and anaerobic media (brucella blood agar, laked blood kanamycin
vancomycin agar, and phenyethyl alcohol agar) were held for 5 days and remained
negative for growth for the duration of incubation. A transesophageal echocardiogram
was negative for vegetations on the heart valves, and the patient was initiated on
intravenous (i.v.) vancomycin, which was subsequently narrowed to i.v. ceftriaxone
once susceptibility testing was available. Two follow-up blood cultures taken 24 h after
the initiation of antimicrobial therapy were positive for the same microorganism. The
bacteremia was ultimately cleared after another 2 days, and the patient was discharged
home on i.v. ceftriaxone for 6 weeks. Surveillance blood cultures taken 2 weeks after the
completion of therapy were negative, and at a subsequent outpatient clinic follow-up at 3
months, she reported complete resolution of her back pain and night sweats. Follow-up
imaging of her spine revealed stable vertebral fractures with no disease progression.
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A thorough review of the patient’s social history revealed that she had a pet
Labrador retriever with a chronic ear infection for the past 8 months. A call to the
veterinarian conﬁrmed purulent otitis, and pus from the dog’s ear was obtained for
culture, which grew S. schleiferi. The patient recalled cleaning the dog’s ear with her
bare hands. She was employed as a housekeeper and had intermittent skin cracks at her
ﬁngertips due to exposure to chemicals, which we postulated might have been the
portal of entry for the microbe.
DISCUSSION
Several bacteria that cause human infections are associated with dogs, including
Pasteurella canis, Capnocytophaga canimorsus, Streptococcus canis, and Staphylococcus
intermedius group (SIG). These organisms are often associated with wound infections
from dog bites, as they are common inhabitants of the oral mucosa of dogs. S. schleiferi
bacteria are thought to be part of the normal skin ﬂora of dogs and are commonly
associated with canine otitis externa and pyoderma (1). This species is divided into two
subspecies, S. schleiferi subsp. schleiferi and S. schleiferi subsp. coagulans. S. schleiferi
subsp. schleiferi is more commonly associated with human infections, including skin
and soft tissue infections, device infections, osteomyelitis, and bacteremia (2). Few
cases of human infection caused by S. schleiferi subsp. coagulans have been docu-
mented, although wound infections, endocarditis, and device infections have been
reported. Immunosuppression, malignancies, and recent surgical procedures are im-
portant comorbidities reported in prior case series and point toward nosocomial
acquisition (3). However, the association of S. schleiferi with canine and human infec-
tions supports the possibility that transmission from dogs to humans can occur, as is
likely in the case presented here.
S. schleiferi bacteria are facultatively anaerobic, Gram-positive cocci. Colonies are
round and nonpigmented and are beta-hemolytic on sheep blood agar (Fig. 1). Several
biochemical reactions differentiate S. schleiferi from other Staphylococcus species that
cause human infections. S. schleiferi is characteristically pyrrolidonyl arylamidase (PYR)
positive, ornithine decarboxylase negative, alkaline phosphatase positive, and suscep-
tible to novobiocin and polymyxin B (4).
Identiﬁcation systems vary in their performance characteristics for S. schleiferi iden-
tiﬁcation. One study found that 22 isolates of S. schleiferi were identiﬁed 100% of the
time by MALDI-TOF with both the Bruker Biotyper and the Vitek2 system (GP no. 21342;
FIG 1 (A and B) S. schleiferi growth on sheep blood agar after 24 h of incubation of the human (A) and
canine (B) isolates. Hemolysis is visible in the smaller image. (C) Christensen’s medium for the detection
of urease production. () and () indicate positive and negative controls, respectively. (D) Latex
agglutination (StaphTEX) of the human and canine isolates.
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bioMérieux) (5). In our case, the Bruker Biotyper MALDI-TOF identiﬁed both the human
and canine isolates to the species level with acceptable scores of 2.143 and 2.245,
respectively. Both isolates were also assayed on the Vitek MS and identiﬁed as S.
schleiferi with a score of 99.9%. Neither system identiﬁed the isolates to the subspecies
level. This species is also included in the database of MicroScan systems and the API
Staph biochemical proﬁling system (bioMérieux); however, little is known about the
performance of these systems for the identiﬁcation of S. schleiferi. Notably, identi-
ﬁcation systems often recommend additional testing such as sugar fermentation to
conﬁrm an identiﬁcation of S. schleiferi.
Differentiation of the two subspecies is possible through biochemical testing with
the tube coagulase and urease reactions. S. schleiferi subsp. schleiferi is slide coagulase
(clumping factor) positive, tube coagulase (free coagulase) negative, and urease neg-
ative, while S. schleiferi subsp. coagulans is negative by slide coagulase testing and
positive by urease and tube coagulase testing. Interestingly, recent genetic analysis of
several clinically relevant Staphylococcus species found that, unlike Staphylococcus
aureus, S. schleiferi does not possess the coa gene that encodes the staphylocoagulase
protein. Thus, the coagulase activity of S. schleiferi is likely mediated by other mecha-
nisms (6). The patient and canine isolates described in the case presentation exhibited
the same morphological and biochemical characteristics, further supporting a zoonotic
source for the patient’s infection (Fig. 1). Both isolates were positive by tube coagulase
and for PYR and urease production. Although we did not report the human isolate
to the subspecies level, these characteristics supported the idea that both the human
and canine isolates were likely S. schleiferi subsp. coagulans because of the positive
urease and tube coagulase reactions. Latex agglutination testing (StaphTEX; Hardy
Diagnostics) produced a questionable weakly positive result with both the human and
canine isolates in our case (Fig. 1). Similar to another clumping factor-positive species,
Staphylococcus lugdunensis, S. schleiferi lacks protein A and may produce a rough or
“stringy” reaction if tested by latex agglutination.
Because of the microbiological and pathological characteristics of S. schleiferi, the
incidence of infections caused by this organism may be underrecognized and under-
reported. Gram-positive cocci in clusters with a positive tube coagulase (S. schleiferi
subsp. coagulans) or slide agglutination (S. schleiferi subsp. schleiferi) reaction may be
misidentiﬁed as S. aureus. Unlike S. aureus, S. schleiferi does not acidify maltose,
mannitol, or sucrose. In addition, a positive reaction for PYR should raise suspicion that
an isolate is not S. aureus. Coagulase-positive staphylococcal isolates that are PYR
positive ﬁt the description of S. schleiferi subsp. coagulans or SIG. These species can be
separated biochemically by fermentation of sucrose and mannose, which is positive for
SIG. Importantly, MALDI-TOF MS can accurately separate S. schleiferi from other coagulase-
positive staphylococcal organisms.
Beta-lactam resistance mediated by mecA (PBP2a) in staphylococcal isolates is a
major concern in human and veterinary infections. In one study, 57% of the clinical
isolates of S. schleiferi from dogs were methicillin resistant (1). While cefoxitin is used as
the surrogate for methicillin resistance in S. aureus, there is evidence that it is not a
sensitive predictor of methicillin resistance in S. schleiferi and SIG. Instead, oxacillin disk
diffusion is more effective at predicting methicillin resistance in SIG and S. schleiferi (7).
The performance of an alternative method of mecA detection, rapid detection of the
mecA gene product PBP2a, has been assessed for S. schleiferi. An evaluation of the Alere
PBP2a immunochromatographic assay found that it was 100% sensitive and speciﬁc for
the differentiation of mecA-positive and -negative clinical isolates of S. schleiferi subsp.
coagulans with mecA PCR as a gold standard (8). The human and canine isolates in our
case were tested by disk diffusion. Both isolates were pansusceptible to all of the
antibiotics tested in our panel, providing supporting evidence that the human and
canine isolates were from the same source (Table 1). While there are no interpretive
criteria for oxacillin disk diffusion, the oxacillin result would be interpreted as suscep-
tible when using the SIG criterion of 18 mm as susceptible (Table 1) (9).
In summary, S. schleiferi is an uncommon but important cause of human infection
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that may be mistaken for S. aureus or other Staphylococcus species. While MALDI-TOF
MS analysis can differentiate most Staphylococcus species, additional biochemical
testing may be necessary for clinical laboratories that do not use these systems.
Differentiation of the species is important, as the presence of mecA is common in S.
schleiferi, but methods for detection of methicillin resistance differ between staphylo-
coccal species. Last, a thorough history of exposures, including animal contact, is
important for interpreting microbiological results in a clinical context.
SELF-ASSESSMENT QUESTIONS





2. A Gram-positive coccus in clusters tests positive for catalase and PYR but
negative for urease and ornithine decarboxylase. What is the most likely identity
of this organism?
A. S. aureus
B. S. schleiferi subsp. schleiferi
C. S. schleiferi subsp. coagulans
D. S. lugdunensis
3. Which of the following methods is a rapid test that could be used to predict
methicillin resistance in S. schleiferi?
A. PBP2a testing by immunochromatographic assay
B. Ceﬁnase test
C. Cefoxitin disk diffusion
D. Oxacillin disk diffusion
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Cefoxitin 30 Susceptible 32 Susceptible
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Erythromycin 27 Susceptible 28 Susceptible
Clindamycin 26 Susceptible 27 Susceptible
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20 Susceptible 19 Susceptible
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Daptomycin 0.064b Susceptible 0.064b Susceptible
aNo CLSI disk diffusion breakpoints are available for oxacillin.
bEtest MIC (g/ml).
The Brief Case Journal of Clinical Microbiology





ber 7, 2017 by W






Staphylococcus schleiferi infection. Eur J Clin Microbiol Infect Dis 20:
153–158. https://doi.org/10.1007/s100960100467.
4. Becker K, Skov RL, Von Eiff C. 2015. Staphylococcus,Micrococcus, and other
catalase-positive cocci, p 354–382. In Jorgensen JH, Pfaller MA, Carroll KC,
Funke G, Landry ML, Richter SS, Warnock DW (ed), Manual of clinical
microbiology, 11th ed, vol 1. ASM Press, Washington, DC.
5. Delport JA, Peters G, Diagre D, Lannigan R, John M. 2015. Identiﬁcation of
coagulase-negative staphylococci by the Bruker MALDI-TOF Biotyper
compared to the Vitek 2 and MIS gas liquid chromatography. J Bacteriol
Mycol Open Access 1(1):00003. https://doi.org/10.15406/jbmoa.2015.01
.00003.
6. Misic AM, Cain CL, Morris DO, Rankin SC, Beiting DP. 2016. Divergent
isoprenoid biosynthesis pathways in Staphylococcus species constitute
a drug target for treating infections in companion animals. mSphere
1:e00258-16. https://doi.org/10.1128/mSphere.00258-16.
7. Bemis DA, Jones RD, Hiatt LE, Ofori ED, Rohrbach BW, Frank LA, Kania SA.
2006. Comparison of tests to detect oxacillin resistance in Staphylococcus
intermedius, Staphylococcus schleiferi, and Staphylococcus aureus isolates
from canine hosts. J Clin Microbiol 44:3374–3376. https://doi.org/10
.1128/JCM.01336-06.
8. Arnold AR, Burnham CA, Ford BA, Lawhon SD, McAllister SK, Lonsway D,
Albrecht V, Jerris RC, Rasheed JK, Limbago B, Burd EM, Westblade LF.
2016. Evaluation of an immunochromatographic assay for rapid detection
of penicillin-binding protein 2a in human and animal Staphylococcus
intermedius group, Staphylococcus lugdunensis, and Staphylococcus
schleiferi clinical isolates. J Clin Microbiol 54:745–748. https://doi.org/10
.1128/JCM.02869-15.
9. CLSI. 2016. Performance standards for antimicrobial susceptibility testing;
twenty-sixth informational supplement. CLSI document M100-S26. Clini-
cal and Laboratory Standards Institute, Wayne, PA.
The Brief Case Journal of Clinical Microbiology





ber 7, 2017 by W
ashington University in St. Louis
http://jcm.asm.org/
D
ow
nloaded from
 
